Literature DB >> 15807525

Effect of a Y265F mutant on the transamination-based cycloserine inactivation of alanine racemase.

Timothy D Fenn1, Todd Holyoak, Geoffrey F Stamper, Dagmar Ringe.   

Abstract

The requirement for d-alanine in the peptidoglycan layer of bacterial cell walls is fulfilled in part by alanine racemase (EC 5.1.1.1), a pyridoxal 5'-phosphate (PLP)-assisted enzyme. The enzyme utilizes two antiparallel bases focused at the C(alpha) position and oriented perpendicular to the PLP ring to facilitate the equilibration of alanine enantiomers. Understanding how this two-base system is utilized and controlled to yield reaction specificity is therefore a potential means for designing antibiotics. Cycloserine is a known alanine racemase suicide substrate, although its mechanism of inactivation is based on transaminase chemistry. Here we characterize the effects of a Y265F mutant (Tyr265 acts as the catalytic base in the l-isomer case) of Bacillus stearothermophilus alanine racemase on cycloserine inactivation. The Y265F mutant reduces racemization activity 1600-fold [Watanabe, A., Yoshimura, T., Mikami, B., and Esaki, N. (1999) J. Biochem. 126, 781-786] and only leads to formation of the isoxazole end product (the result of the transaminase pathway) in the case of d-cycloserine, in contrast to results obtained using the wild-type enzyme. l-Cycloserine, on the other hand, utilizes a number of alternative pathways in the absence of Y265, emphasizing the importance of Y265 in both the inactivation and racemization pathway. In combination with the kinetics of inactivation, these results suggest roles for each of the two catalytic bases in racemization and inactivation, as well as the importance of Y265 in "steering" the chemistry to favor one pathway over another.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807525     DOI: 10.1021/bi047842l

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Inhibition of the PLP-dependent enzyme serine palmitoyltransferase by cycloserine: evidence for a novel decarboxylative mechanism of inactivation.

Authors:  Jonathan Lowther; Beverley A Yard; Kenneth A Johnson; Lester G Carter; Venugopal T Bhat; Marine C C Raman; David J Clarke; Britta Ramakers; Stephen A McMahon; James H Naismith; Dominic J Campopiano
Journal:  Mol Biosyst       Date:  2010-05-05

2.  The Recognition of Identical Ligands by Unrelated Proteins.

Authors:  Sarah Barelier; Teague Sterling; Matthew J O'Meara; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2015-10-12       Impact factor: 5.100

Review 3.  Molecular dynamics simulations of the intramolecular proton transfer and carbanion stabilization in the pyridoxal 5'-phosphate dependent enzymes L-dopa decarboxylase and alanine racemase.

Authors:  Yen-Lin Lin; Jiali Gao; Amir Rubinstein; Dan Thomas Major
Journal:  Biochim Biophys Acta       Date:  2011-05-10

4.  Crystallization and preliminary X-ray diffraction analysis of alanine racemase from Pseudomonas putida YZ-26.

Authors:  Junlin Liu; Lei Feng; Yawei Shi; Wei Feng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-09-29

5.  Chemical Mechanism of the Branched-Chain Aminotransferase IlvE from Mycobacterium tuberculosis.

Authors:  Tathyana M Amorim Franco; Subray Hegde; John S Blanchard
Journal:  Biochemistry       Date:  2016-11-02       Impact factor: 3.162

6.  Involvement of ceramide in ethanol-induced apoptotic neurodegeneration in the neonatal mouse brain.

Authors:  Mariko Saito; Goutam Chakraborty; Medha Hegde; Jason Ohsie; Sun-Mee Paik; Csaba Vadasz; Mitsuo Saito
Journal:  J Neurochem       Date:  2010-08-12       Impact factor: 5.372

7.  The crystal structure of alanine racemase from Streptococcus pneumoniae, a target for structure-based drug design.

Authors:  Hookang Im; Miriam L Sharpe; Ulrich Strych; Milya Davlieva; Kurt L Krause
Journal:  BMC Microbiol       Date:  2011-05-25       Impact factor: 3.605

8.  Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630.

Authors:  Oluwatoyin A Asojo; Sarah K Nelson; Sara Mootien; Yashang Lee; Wanderson C Rezende; Daniel A Hyman; Monica M Matsumoto; Scott Reiling; Alan Kelleher; Michel Ledizet; Raymond A Koski; Karen G Anthony
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.